Massachusetts Financial Services’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
GCL
TAL
HI
BCM
MF
Massachusetts Financial Services's SWTX Position: Q2 2025 in Review
Massachusetts Financial Services sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 354,505 shares — an estimated $15.6M sold.
Massachusetts Financial Services first reported a position in SWTX in Q3 2019 and held it in 23 quarters. The position peaked at $32.4M in Q2 2021. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.
- Massachusetts Financial Services reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
- Massachusetts Financial Services sold 354,505 SpringWorks Therapeutics shares in Q2 2025, an estimated $15.6M.
- Massachusetts Financial Services first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 23 quarters.
- Massachusetts Financial Services's SpringWorks Therapeutics position peaked at $32.4M in Q2 2021.
- 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.
Based on Massachusetts Financial Services's 13F filing for Q2 2025, filed 8 Aug 2025.